学位論文 The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer

Kawaguchi, Gen  ,  川口, 弦

pp.1 - 7 , 2015-09-24 , 新潟大学
内容記述
学位の種類: 博士(医学). 報告番号: 甲第4059号. 学位記番号: 新大院博(医)甲第648号. 学位授与年月日: 平成27年9月24日
Radiation Oncology. 2015, 10, 31.
Background: To evaluate the risks and benefits of endoscopic submucosal dissection (ESD) in addition to chemoradiotherapy (CRT) for the treatment of superficial esophageal squamous cell carcinoma (SESCC). Methods and materials: We retrospectively reviewed the treatment outcomes of 47 patients with SESCC treated between October 2000 and December 2011. Sixteen patients with invasion into the submucosal layer (T1b) or the muscularis mucosa (m3) with positive vascular invasion were treated with CRT after ESD(ESD-CRT group). The lymph node area was irradiated to a total dose of 40–44 Gy and a boost radiation was administered if PET-positive lymph nodes or positive margins were observed. The remaining 31 patients received definitive CRT only (dCRT group). Results: The radiation field was significantly larger in the ESD-CRT group; the "long T" was used in 11 patients (35.4%) in the dCRT group and 15 (93.7%) in the ESD-CRT group (p = 0.0001). The total radiation dose was smaller in the ESD-CRT group; 40 Gy was used in 10 patients (62.5%) in the ESD-CRT group and all but one patient in the dCRT group received ≥60 Gy (p = 0.00001). The 3-year overall survival rates in the dCRT and ESD-CRT groups were 63.2% and 90.0% respectively (p = 0.118). Recurrence developed in nine patients (29.0%) in the dCRT group and one (6.3%) in the ESD-CRT group. Local recurrence was observed in six patients (19%) in the dCRT group and none in the ESD-CRT-group (p = 0.029). Pericardial effusion (≥Grade 3) occurred in three patients (9.7%) in the dCRT group and none in the ESD-CRT group. Conclusions: ESD followed by CRT is an effective and safe approach for SESCC at m3 or T1b. This combination of ESD and CRT improves the local control rate, and it could decrease the number of cardiac toxicities due to a radiation-dose reduction relative to CRT alone.
本文を読む

http://dspace.lib.niigata-u.ac.jp/dspace/bitstream/10191/35551/1/h27nmk648_a.pdf

http://dspace.lib.niigata-u.ac.jp/dspace/bitstream/10191/35551/2/h27nmk648.pdf

このアイテムのアクセス数:  回

その他の情報